Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Double‐blind, randomised trial. Random number generation done centrally. Double‐blinded by use of identical placebos. Allocation concealment achieved by sealed, sequentially numbered, tinted bottles filled and labelled by the manufacturer
Participants 1324 women in 16 urban family planning clinics in China
Included only women who came within 72 h of unprotected intercourse
Excluded women with irregular menstrual periods, with multiple acts of intercourse, on oral contraceptives and post‐abortal women whose menstrual periods had not returned to normal
Interventions LNG 0.75 mg, 2 doses, 12 h apart vs Mife 10 mg, single dose
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. 20 women excluded altogether (reasons not stated)

  2. Loss to follow‐up 28 (2.1%) in the 2 groups

  3. Observed pregnancy/expected pregnancy/total number of women: LNG 20/49/643; Mife 9/44/633

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random number generation done centrally
Allocation concealment (selection bias) Low risk Allocation concealment achieved by sealed, sequentially numbered, tinted bottles filled and labelled by the manufacturer
Blinding (performance bias and detection bias) All outcomes Low risk Double‐blind
Incomplete outcome data (attrition bias) All outcomes Low risk Post‐randomisation exclusion and loss to follow‐up reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected